https://www.nejm.org/doi/full/10.1056/NEJMoa2209051
0
0
8/28/22 at 6:33am
Organization
nejm.org
28 words
0
Comments
Original Article from The New England Journal of Medicine — Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
You are the first to view
Create an account
or login to join the discussion